CEO Blog discusses May 9th AFR article on an experimental form of therapy for late-stage prostate cancer

May 11th, 2018 by Blog Author

An  article appeared in the AFR this week. ‘Billion-dollar molecule’ may extend life in men with prostate cancer – Australian Financial Review, May 9 2018 It concerns a clinical trial being conducted in Australia of a promising experimental form of therapy for late-stage prostate cancer. I have been asked where our efforts with NOX66 in […]

Read More